Abstract
AbstractThe monocyclo‐diendiyne → bicyclo‐trienediyne strategy for obtaining dienediyne models of the antitumor antibiotic neocarzinostatin chromophore (1) was extended from generating 6‐/11‐membered bicyclotrienediynes (e.g. 2 → 4) to generating the 6‐/10‐membered bicyclotrienediyne 5. In the preparatory steps (Scheme 2), the bistriflate 10 was successively coupled with alkynes 9 and 11. Via the dienediynediol and its subsequent oxidation with the Dess‐Martin periodinane, we obtained the monocyclic dienediyne keto aldehyde 13. Cyclization of 13 with low‐valent titanium afforded the bicyclotrienediyne 5 in 42% yield (Scheme 3). Compound 5 was converted in five steps – namely ketal cleavage, monosilylation of the resulting diol 14, asymmetric Sharpless epoxidation, desilylation and carbonate formation – into the dienediyne epoxycarbonate 3. The structure of the latter is more closely related to the neocarzinostatin chromophore than our earlier analogues.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.